Life Sciences Archivi - World Wide Trends

24 marzo 2025

North America Leads the Contactless Biometrics Market Expansion

According to the latest market research study published by P&S Intelligence, the global contactless biometrics market is experiencing significant growth, projected to reach a value of USD 81.6 billion by 2032, up from USD 21.5 billion in 2024, growing at a compound annual growth rate (CAGR) of 18.3% during the forecast period (2025–2032).

The adoption of contactless biometric technologies is driven by increasing security concerns, advancements in biometric systems, and government initiatives supporting their implementation. Contactless biometrics are widely used across sectors, including government, defense, transport, healthcare, and financial institutions, with applications ranging from criminal identification and access control to seamless travel experiences. The market is also benefiting from the surge in contactless payment systems and rising awareness of digital identity security.

Key Insights

Segmentation Analysis:

The software segment holds the largest market share, contributing over 45% in 2024. This segment is expected to see the fastest growth due to the increasing demand for software solutions that enhance compatibility and security features across devices.

Face recognition technology dominates the market, driven by its widespread use and high security. Iris recognition technology is expected to experience the highest growth, as it offers advantages over facial recognition, particularly in terms of accuracy and security.

Regional and Geographical Trends:

North America is the largest market for contactless biometrics, with Asia-Pacific emerging as the fastest-growing region. This growth is attributed to the increased adoption of biometric systems in public and private sectors, especially in countries like India, where initiatives such as Aadhaar’s contactless biometric verification are expanding.

The government sector remains the largest revenue contributor, with significant adoption seen in airports, government buildings, and immigration checkpoints for enhanced security and seamless operations.

Technological Advancements:

AI and machine learning technologies are increasingly being integrated into contactless biometric systems, improving accuracy and performance. Additionally, advancements in facial recognition software and hardware are facilitating the growth of contactless payments and security systems.

The demand for contactless biometric cards is rising due to their convenience in transactions, especially in sectors like banking and retail.

Competitive Dynamics and Opportunities:

Major players are focusing on enhancing facial recognition systems and expanding their portfolios in contactless biometric solutions. As the technology becomes more affordable, companies are leveraging it to improve security in both public and private sectors.

Rising concerns over identity theft and fraudulent activities are driving demand across sectors such as banking, defense, and healthcare, creating opportunities for companies to innovate and provide integrated biometric solutions.

This expansive growth in the contactless biometrics market is reshaping security standards across various industries, offering businesses new avenues for growth through advanced biometric technologies.

19 marzo 2025

Patient Referral Management Software Market Set for 17.9% CAGR Through 2030

According to the latest market research study published by P&S Intelligence, the global patient referral management software market was valued at USD 9,598.3 million in 2023 and is expected to experience robust growth, with a CAGR of 17.9% from 2024 to 2030, reaching USD 30,221.2 million by the end of the forecast period. This growth is primarily driven by an aging global population, increased government initiatives promoting healthcare IT adoption, and continuous technological advancements. The software’s role in streamlining referral processes, enhancing communication among healthcare professionals, and improving patient care quality is also a significant factor supporting its widespread adoption.

Technological innovations, such as cloud-based solutions, electronic prescriptions, and integrated health records, further enhance the efficiency and accuracy of patient referral management. These advancements are poised to address the challenges of referral leakage, patient tracking, and communication barriers, thus contributing to the market’s expansion.

Key Insights

The patient referral management software market is segmented into software and services, with the software category holding the largest share in 2023. It is expected to grow rapidly due to its enhanced accuracy and efficiency in managing healthcare operations.

The inbound referrals segment is projected to witness the fastest growth, with a CAGR of 17.9% from 2024 to 2030, as hospitals increasingly utilize digital platforms to handle the influx of referrals.

Cloud-based solutions are expected to dominate the market, thanks to their cost-efficiency, scalability, and better data security compared to on-premises systems. Healthcare providers are increasingly adopting cloud solutions for their operational flexibility.

The providers category is expected to be the largest and fastest-growing end-user segment, advancing at a CAGR of 18.2%. Healthcare providers benefit from improved coordination, reduced referral leakage, and automated processes, ultimately enhancing operational efficiency.

North America holds the largest market share, with strong growth driven by the region’s advanced healthcare infrastructure, increasing adoption of telehealth, and growing use of artificial intelligence and data analytics in healthcare.

Geriatric care is a significant driver for the market, as the elderly population requires efficient, timely access to specialized healthcare. Referral management software ensures better coordination and care for the aging population.

Technological developments, including the integration of electronic health records and the rise of digital health solutions, are key factors accelerating market growth, optimizing referral processes, and improving overall patient satisfaction.

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

17 marzo 2025

Gene Cloning Services Demand Surges Amid Biotech Growth

According to the latest market research study published by P&S Intelligence, the global gene cloning services market is experiencing remarkable growth, with its value estimated at USD 3,154.1 million in 2023 and projected to reach USD 10,019.6 million by 2030, reflecting a robust CAGR of 18.1% during the forecast period.

This surge is primarily driven by the increasing prevalence of chronic diseases, a heightened demand for precision medicine, and significant advancements in genetic research. The rise in healthcare expenditure by governments, coupled with the expansion of the biotechnology industry, further propels the market’s growth.

Key Insights

Service Segmentation

The gene cloning services market is categorized into custom cloning, molecular biology, and gene synthesis services. Among these, custom cloning services hold a substantial share, attributed to their tailored solutions catering to specific research and therapeutic needs.

Application Spectrum

Gene cloning finds extensive applications across various domains:

Gene Therapy: Utilized in correcting defective genes responsible for disease progression.
Vaccine Research: Plays a pivotal role in developing recombinant vaccines, enhancing immunogenicity and safety profiles.
Agricultural Sector: Employed in creating genetically modified crops with improved yield and resistance to pests.

Gene Type Analysis

The market differentiates between standard and complex genes. Complex gene cloning services are witnessing increased demand due to the intricate nature of multi-gene disorders and the necessity for comprehensive therapeutic strategies.

End-User Dynamics

The primary consumers of gene cloning services include:

Clinical Laboratories: Rely on cloning techniques for accurate disease diagnosis and research.
Pharmaceutical & Biotechnology Firms: Utilize these services for drug discovery, development, and personalized medicine approaches.

Regional Trends

North America leads the market, driven by advanced healthcare infrastructure, substantial research funding, and a high adoption rate of innovative technologies. Europe follows suit, with significant contributions to biotechnology research. The Asia-Pacific region is emerging rapidly, attributed to increasing investments in healthcare and biotechnology sectors.

Technological Advancements

Innovations such as CRISPR-Cas9 and other gene-editing technologies have revolutionized gene cloning, making processes more efficient and cost-effective. These advancements facilitate precise modifications, thereby broadening the scope of therapeutic applications.

Competitive Landscape

The market is characterized by the presence of key players offering a wide range of services. Companies are focusing on strategic collaborations, mergers, and acquisitions to enhance their service portfolios and global reach.

Emerging Opportunities

The rising focus on personalized medicine and the increasing prevalence of genetic disorders present lucrative opportunities. Additionally, the agricultural sector’s demand for genetically modified organisms (GMOs) to ensure food security opens new avenues for market expansion.

12 marzo 2025

Rising Demand for Biologic Drugs Boosts Red Biotechnology

According to the latest market research study published by P&S Intelligence, the global red biotechnology market is poised for significant growth, with revenue estimated at $576.7 billion in 2023 and projected to reach $1,172.3 billion by 2030, reflecting a robust CAGR of 10.8% during the forecast period (2024–2030).

This surge is primarily driven by the increasing application of genetic engineering in biologic drug production and the escalating demand for personalized medicines. Additionally, advancements in gene sequencing technologies and substantial investments from both government and private sectors are propelling large-scale biotechnology projects. The expanding utilization of red biotechnology across various fields, including poultry farming, veterinary sciences, and tissue engineering, further contributes to market growth.

Key Insights

Application Segmentation

Red biotechnology is extensively employed in the development of human vaccines, antibiotics, new drug formulations, molecular diagnostic techniques, and regenerative therapies.

Product Segmentation

The market encompasses a diverse range of products, including diagnostic reagents, human vaccines, blood products, gene recombinant drugs, and personalized medicines.

End-User Segmentation

Key end users include the biopharmaceutical industry, contract manufacturing organizations (CMOs), contract research organizations (CROs), and research institutes.

Regional Trends

The market exhibits significant growth across various regions, propelled by increasing investments in biotechnology research and development, coupled with a rising prevalence of chronic diseases.

Technological Advancements

Innovations in gene sequencing platforms and tissue engineering techniques are enhancing the development of key surgical implements, such as artificial bones, cartilage, and spinal discs. These advancements are expanding the therapeutic applications of red biotechnology.

Competitive Dynamics

The market is characterized by active research and development initiatives from key biopharmaceutical companies, supported by governmental policies and funding. This collaborative environment fosters the development of new drug molecules and therapeutic solutions.

Emerging Opportunities

The rising prevalence of chronic diseases globally underscores the need for innovative biologic drugs. Red biotechnology offers promising avenues for developing targeted therapies and personalized medicine, addressing the growing healthcare demands.

In summary, the red biotechnology market is on a trajectory of substantial growth, driven by technological advancements, increasing healthcare needs, and collaborative efforts in research and development. These factors collectively contribute to the expanding scope and application of red biotechnology in modern medicine.

5 marzo 2025

FDA Approvals Boost Radioligand Therapy Adoption Worldwide

According to the latest market research study published by P&S Intelligence, the radioligand therapy market has experienced significant growth, with its size estimated at $9,205.9 million in 2024. Projections indicate a CAGR of 6.4% from 2024 to 2030, reaching approximately $13,350.6 million by 2030. This expansion is primarily driven by the increasing number of FDA-approved drugs exhibiting low side effects, coupled with heightened research activities in cancer treatment. Additionally, the rising demand for more effective therapeutic options has further propelled market growth.

Government initiatives, such as the European Commission’s “Europe’s Beating Cancer Plan” launched in February 2021, aim to enhance cancer services with a focus on prevention and early diagnosis. In 2022, the European government allocated over $4.2 billion to cancer research and care, underscoring the commitment to combating the disease. These efforts have bolstered the adoption of radiopharmaceuticals and radiotherapy, known for their efficacy in treating malignancies, thereby augmenting market growth.

Key Insights

Segmentation Analysis:

Indication: The market is segmented based on indications, with prostate cancer and neuroendocrine tumors being the primary focus areas.
Drug: Key drugs in the market include Lutathera, Pluvicto, Xtandi, Xofigo, and Zytiga.
End User: Major end users encompass hospitals, clinics, and academic and research institutes.
Distribution Channel: The distribution channels are categorized into direct and indirect channels.

Regional and Geographical Trends:

Largest Region: North America holds the largest share of the radioligand therapy market, attributed to advanced healthcare infrastructure and significant research investments.
Fastest-Growing Region: The Asia-Pacific region is anticipated to exhibit the fastest growth, driven by increasing healthcare expenditure and rising awareness about advanced cancer therapies.

Technological Advancements Shaping the Market:

Advancements in radiopharmaceuticals have led to the development of targeted therapies with minimal side effects, enhancing patient outcomes.
The establishment of centralized radio-pharmacies has streamlined the availability and distribution of radioligand therapies, improving accessibility for healthcare providers and patients.

Competitive Dynamics, Major Players, and Emerging Opportunities:

The market is characterized as fragmented, with numerous players contributing to its dynamics.
Key players are focusing on the development, approval, and launch of advanced radioligand therapies to meet the growing demand.
Emerging opportunities include the exploration of radioligand therapies for a broader range of cancer types and the integration of novel technologies to enhance treatment efficacy.

The radioligand therapy market is poised for substantial growth, driven by technological advancements, strategic government initiatives, and the continuous efforts of industry players to innovate and expand therapeutic options.

4 marzo 2025

E-Pharmacies Boost Saudi Pharmaceutical Market Expansion

According to the latest market research study published by P&S Intelligence, the Saudi Arabian pharmaceuticals market is poised for significant growth, with projections estimating its value to reach USD 21.8 billion in 2024 and further expand at a CAGR of 4.5%, culminating in USD 28.3 billion by 2030. This upward trajectory is largely driven by the nation’s expanding population and escalating healthcare concerns. In response, the government has been proactive in enhancing and broadening healthcare infrastructure and accessibility, thereby fueling the rapid advancement of the pharmaceutical sector.

A notable contributor to this growth is the increasing prevalence of chronic diseases, such as respiratory disorders and diabetes, primarily attributed to lifestyle changes. For instance, the International Diabetes Federation reported that in 2021, approximately 4,272,100 out of 24,194,300 adults in Saudi Arabia were living with diabetes. These chronic conditions necessitate ongoing medication for effective treatment and management, thereby amplifying the demand for pharmaceutical products.

Key Insights

Product Type Analysis

Prescription Drugs:
- In 2024, prescription drugs are anticipated to constitute 60% of the market share. This dominance is propelled by the rising incidence of chronic diseases, including ischemic heart disease, obesity, and hypertension, which require long-term medication regimens. Additionally, the presence of multinational pharmaceutical companies supplying branded medications through wholesale partners bolsters this segment.
Over-the-Counter (OTC) Drugs:
- While prescription drugs lead in market share, OTC drugs are experiencing faster growth. This surge is linked to the availability of medications for general conditions, such as common colds and headaches, which consumers can purchase without a doctor’s prescription.

Distribution Channel Analysis

Retail Pharmacies:
- Retail pharmacies are projected to hold a 45% market share in 2024. Their adoption of modern retail practices, such as efficient inventory management, organized store layouts, and enhanced customer service, makes them increasingly appealing to consumers. Moreover, these pharmacies offer the convenience of medication refills without necessitating hospital visits.

Indication Analysis

Cardiovascular Diseases (CVDs):
- CVDs are expected to account for the highest market revenue. A study indicates an overall CVD prevalence of 1.6% across all provinces in Saudi Arabia, with higher rates among males (1.9%) compared to females (1.4%). Furthermore, the National Library of Medicine identifies CVDs as a leading cause of mortality in the country, responsible for approximately 45.7% of deaths. The chronic nature of many CVDs necessitates long-term treatment and careful management, thereby driving demand for related medications.
Diabetes:
- Diabetes is identified as the fastest-growing category within the pharmaceuticals market. The substantial number of adults living with diabetes underscores the escalating demand for effective diabetic treatments and management solutions.

Regional Analysis

Al-Riyadh:
- Al-Riyadh is leading the market with a 35% share in 2024. This prominence is attributed to its status as a central hub for major pharmaceutical companies and hospitals. The province’s sophisticated logistics and cold-chain infrastructure further enhance its attractiveness for pharmaceutical distribution.
Eastern Region:
- The Eastern Region is projected to experience a CAGR of 4.8% during the forecast period. This growth is driven by enhancements in healthcare infrastructure and a burgeoning population, both of which contribute to increased demand for pharmaceutical products.

Technological Advancements

E-Pharmacies:

A significant trend in the Saudi Arabian pharmaceuticals market is the growing utilization of e-pharmacies. In 2022, approximately 92% of the population owned smartphones, facilitating easy access to online medicine ordering platforms. E-pharmacies offer benefits such as convenient access, home deliveries, prescription management solutions, product information, and counseling services, thereby enhancing the consumer experience. Government support for e-commerce and digitalization further propels the growth of e-pharmacies.

Competitive Landscape

The Saudi Arabian pharmaceuticals market is characterized by high competitiveness, with several major players, including Tabuk Pharmaceuticals and Al Tadawi Healthcare, actively participating. Government initiatives promoting local companies, along with insurance and healthcare reforms, have led to an increase in the number of operating players. Intense competition among pharmaceutical companies in pricing strategies, supply chain management, and promotional campaigns further intensifies the market dynamics.

In summary, the Saudi Arabian pharmaceuticals market is on a robust growth trajectory, driven by factors such as an increasing prevalence of chronic diseases, technological advancements like e-pharmacies, and strategic government initiatives aimed at enhancing healthcare infrastructure and accessibility. The market’s segmentation across product types, distribution channels, indications, and regions offers diverse opportunities for stakeholders to capitalize on emerging trends and address evolving healthcare needs.

h    238.922
w    580
238.922
580
24

3 marzo 2025

Global Demand for Surgical Instrument Tracking on the Rise

The global surgical instrument tracking system market is poised for significant growth, with projections indicating a rise from USD 350.9 million in 2024 to USD 627.4 million by 2030, reflecting a compound annual growth rate (CAGR) of 10.2%. This upward trajectory is primarily driven by technological advancements in healthcare, the increasing need for compliance with Unique Device Identification (UDI) standards, and the rising volume of surgical procedures worldwide. The implementation of UDI regulations mandates that most medical devices carry unique identifiers, enhancing traceability and inventory management. These developments are instrumental in bolstering patient safety and operational efficiency within healthcare facilities.

Key Insights

Segmentation Analysis:

By Component: The market is segmented into software, hardware, and services. The software segment is anticipated to hold a substantial share due to the growing adoption of advanced tracking solutions that streamline instrument management and data analytics.
By Technology: Radio Frequency Identification (RFID) and barcode systems are the primary technologies employed. RFID technology is gaining prominence owing to its ability to provide real-time tracking and reduce manual errors, thereby enhancing operational efficiency.
By End User: Hospitals represent the largest end-user segment, attributed to the high volume of surgical procedures and the critical need for efficient instrument management to ensure patient safety and compliance with regulatory standards.

Regional and Geographical Trends:

North America: This region holds the largest market share, driven by stringent regulatory requirements, advanced healthcare infrastructure, and early adoption of innovative technologies.
Asia-Pacific: Identified as the fastest-growing region, the Asia-Pacific market is expanding due to increasing healthcare investments, rising awareness about patient safety, and the growing number of surgical procedures.

Technological Advancements Shaping the Market:

Integration of advanced technologies such as RFID and barcode systems is a significant trend. These technologies enhance real-time tracking, reduce errors in instrument counts, and improve overall operational efficiency in healthcare settings.
For instance, new intelligent delivery platforms specifically designed for high-volume foot and ankle procedures in ambulatory surgery centers (ASCs) incorporate RFID technology to seamlessly monitor ASC inventory.

Competitive Dynamics, Major Players, and Emerging Opportunities:

The market is characterized by a fragmented landscape with several key players striving to enhance their market position through strategic initiatives. Major companies include:

- Stryker Corporation: Known for its innovative surgical solutions, including the integration of RFID technology in instrument tracking systems.
- BD (Becton, Dickinson and Company): Offers comprehensive instrument tracking solutions focusing on enhancing patient safety and operational efficiency.
- Censis Technologies, Inc.: Specializes in surgical instrument tracking systems that improve asset management and compliance.

Emerging opportunities in the market include the development of cloud-based tracking solutions, integration with electronic health records (EHRs), and the expansion of services in emerging economies where healthcare infrastructure is rapidly evolving.

The surgical instrument tracking system market is on a robust growth trajectory, propelled by technological innovations, regulatory mandates, and the imperative to enhance patient safety and operational efficiency. Stakeholders are increasingly focusing on adopting advanced tracking technologies and expanding their presence in emerging markets to capitalize on the burgeoning opportunities in this sector.

28 febbraio 2025

Global Healthcare Facility Management Market Set for 8.5% CAGR

According to the latest market research study published by P&S Intelligence, the global healthcare facility management market is poised for significant growth, with projected revenues increasing from USD 110.3 billion in 2024 to USD 180.0 billion by 2030, reflecting a compound annual growth rate (CAGR) of 8.5%.

This expansion is driven by escalating healthcare infrastructure investments, the integration of advanced technologies, and a rising patient population. The prevalence of chronic diseases and infections, coupled with increasing healthcare expenditures, further propels the demand for efficient facility management services. Notably, the adoption of digital solutions such as data analytics, artificial intelligence (AI), the Internet of Things (IoT), and telehealth is revolutionizing hospital operations, offering lucrative opportunities for market participants.

Key Insights

Service Segmentation

Cleaning services dominate the market, attributed to the heightened emphasis on maintaining hygiene standards in healthcare settings. Security services are experiencing rapid growth, driven by the need to safeguard medical facilities and patient data.

Business Model Trends

Outsourced facility management services account for a larger market share, comprising 53.6% in 2021. Healthcare providers are increasingly outsourcing to enhance patient care quality, reduce operational costs, and focus on core medical services.

Regional Dynamics

North America leads the market, benefiting from advanced healthcare infrastructure and significant investments in facility management. The Asia-Pacific region is anticipated to witness the fastest growth, propelled by expanding healthcare facilities and technological adoption.

Technological Advancements

The integration of AI and IoT in facility management is enhancing operational efficiency and energy management within healthcare buildings. Telehealth services are expanding, supported by the widespread availability of mobile internet, enabling remote patient consultations and monitoring.

Competitive Landscape

The market is fragmented, with key players including ABM Industries Inc., Ecolab Inc., Sodexo Group, ISS World Services A/S, and Serco Group PLC. These companies are focusing on strategic acquisitions and partnerships to broaden their service offerings and geographic presence.

Emerging Opportunities

The COVID-19 pandemic has underscored the importance of stringent hygiene and infection control, leading to increased demand for facility management services. Additionally, the integration of digital technologies into hospital workflows presents new avenues for market growth.

About P&S Intelligence

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

27 febbraio 2025

California Tops U.S. Endoscope Repair Market with 15% Share

The U.S. endoscope repair market is poised for significant growth, with projections indicating a rise from USD 533.5 million in 2024 to USD 990.7 million by 2030, reflecting a compound annual growth rate (CAGR) of 11.0% during the forecast period. This expansion is primarily driven by the increasing adoption of minimally invasive surgical procedures, a higher prevalence of gastrointestinal and colorectal diseases, and the inherent need for regular maintenance due to the delicate nature of endoscope components. Additionally, the aging population and the proliferation of healthcare facilities across the nation further bolster the demand for endoscope repair services.

Key Insights

Dominance of Flexible Endoscopes

In 2024, flexible endoscopes are anticipated to constitute approximately 73% of the market share. Their ability to navigate complex internal pathways, coupled with enhanced patient comfort, underscores their widespread preference in medical procedures.

Service Provider Landscape

Original Equipment Manufacturers (OEMs) are projected to remain the predominant service providers in 2024. However, Independent Service Organizations (ISOs) are expected to experience a higher growth trajectory, with a CAGR of 12.2% during the forecast period. This surge is attributed to their competitive pricing models, offering cost-effective solutions without compromising on service quality.

Regional Highlights

California is set to lead the market, accounting for 15% of the revenue share in 2024, and is projected to witness a CAGR of 12.5% through 2030. The state’s extensive network of healthcare facilities and a diverse patient population contribute to the heightened demand for endoscope repair services.

Technological Advancements

The evolution of endoscopic technologies, such as the transition to ultra-high-definition imaging and the integration of narrow-band imaging (NBI), has enhanced diagnostic precision. These advancements necessitate specialized repair and maintenance services to ensure optimal performance.

Competitive Dynamics

The market is characterized by fragmentation, with numerous players including OEMs, ISOs, and in-house hospital repair departments. This diversity fosters a competitive environment, driving service providers to continually enhance their offerings.

Key Market Players

Prominent companies operating in the U.S. endoscope repair market include Smith & Nephew Inc., The Cooper Companies Inc., Intuitive Surgical Inc., Richard Wolf Medical Instruments Corporation, FUJIFILM Holdings America Corporation, KARL STORZ SE & Co. KG, CONMED Corporation, Arthrex Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Stryker Corporation.

Market Fragmentation

The presence of multiple service providers, ranging from established OEMs to emerging ISOs, contributes to a fragmented market landscape. This fragmentation offers healthcare providers a variety of options, fostering competitive pricing and service quality.

Growth Drivers

The market’s expansion is fueled by a combination of factors, including the increasing preference for minimally invasive procedures, a rising incidence of gastrointestinal ailments, and the continuous advancements in endoscopic technologies. These elements collectively enhance the demand for specialized endoscope repair services.

Future Outlook

With the healthcare sector’s ongoing emphasis on technological innovation and patient-centric care, the U.S. endoscope repair market is poised for sustained growth. Service providers that prioritize quality, affordability, and technological adeptness are likely to secure a competitive edge in this evolving landscape.

In summary, the U.S. endoscope repair market is on a robust growth trajectory, driven by technological advancements, a diverse service provider ecosystem, and an increasing demand for minimally invasive medical procedures. Stakeholders are encouraged to capitalize on emerging opportunities to establish a strong foothold in this dynamic market.

About P&S Intelligence

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

25 febbraio 2025

Global Synthetic Biology Industry to Reach $61.2B by 2030

According to the latest market research study published by P&S Intelligence, the global synthetic biology market is experiencing significant growth, with its size projected to increase from $19,228.9 million in 2024 to $61,220.9 million by 2030, reflecting a compound annual growth rate (CAGR) of 21.6% during the period from 2025 to 2030.

This expansion is primarily driven by the declining costs of DNA sequencing and the availability of efficient next-generation sequencing systems at lower prices. Additionally, increased funding and initiatives in synthetic biology research from both governmental and private sectors are contributing to market growth.

Key Insights

Segmentation Analysis:

Tools: The market offers a range of tools, including oligonucleotides and synthetic DNA, enzymes, cloning kits, synthetic cells, chassis organisms, and xeno-nucleic acids.

Technologies: Key technologies driving the market encompass gene synthesis, genome engineering, sequencing, bioinformatics, site-directed mutagenesis, cloning, measurement and modeling, microfluidics, and nanotechnology.

Applications: Synthetic biology finds applications across various sectors such as medical, pharmaceuticals, industrial, food and agriculture, and environmental fields.

Regional and Geographical Trends:

North America: Currently holds the largest share of the synthetic biology market, attributed to advanced research infrastructure and substantial investment in biotechnology.

Asia-Pacific: Anticipated to be the fastest-growing region during the forecast period, driven by increasing adoption of synthetic biology technologies and rising research activities in countries like China and India.

Technological Advancements Shaping the Market:

Next-Generation Sequencing (NGS): The adoption of NGS technologies by pharmaceutical and biopharmaceutical companies is enhancing the development of innovative treatments for chronic diseases, including cancer and autoimmune disorders.

Nanopore Sequencing: Emerging as a key trend, nanopore sequencing technology offers high-throughput sequencing capabilities with reduced costs and increased speed, addressing limitations of traditional methods like Sanger sequencing.

Competitive Dynamics, Major Players, and Emerging Opportunities:

Market Fragmentation: The synthetic biology market is characterized by fragmentation, with numerous applications across healthcare, pharmaceuticals, chemicals, and agriculture sectors.

Key Players: Prominent companies include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript Biotech Corporation, Codexis Inc., Eurofins Scientific SE, Danaher Corporation, New England Biolabs, Illumina Inc., Bio-Rad Laboratories Inc., and Precigen Inc

Emerging Opportunities: The increasing focus on bio-based and sustainable products is creating new avenues for synthetic biology applications, particularly in developing environmentally friendly solutions across various industries.

The synthetic biology market’s robust growth trajectory is underpinned by technological innovations, strategic collaborations, and a rising demand for sustainable and personalized solutions across multiple sectors.

About P&S Intelligence

Contact:
Chandra Mohan
AVP – Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter